【摘要】：目的 探討高齡患者前列腺增生手術(shù)的臨床效果。 方法 選擇2005年1月至2009年1月于我院收治的前列腺增生高齡(大于80歲)患者60例,56例采用經(jīng)尿道前列腺增生等離子電切術(shù),4例采用恥骨上經(jīng)膀胱前列腺增生體摘除術(shù)。對所有患者手術(shù)前后的IPSS評分、殘余尿量和最大尿流量(Qmax)進行比較。 結(jié)果 60例手術(shù)均獲得成功,術(shù)中無明顯包膜穿孔,輸尿管口及尿道括約肌損傷；IPSS評分、殘余尿量和最大尿流率手術(shù)前分別為(20。3±3.7)分、(85.11±13.0)ml和(8.7±2.1)ml／s；手術(shù)后分別為(11.5±2.1)分、(3.7.7±7.9)ml和(14.9±3.2)ml／s；手術(shù)后的IPSS評分和殘余尿量均少于手術(shù)前,最大尿流率Qmax大于手術(shù)前(t=16.02、24.14、12.55,均P0.05)；所有患者術(shù)后均隨訪6～12個月,無尿失禁,無明顯前列腺增生復發(fā)。 結(jié)論 高齡患者前列腺增生行經(jīng)尿道前列腺增生等離子體電切術(shù)安全有效,復發(fā)率低,值得推廣。
[Abstract]:Objective to investigate the clinical effect of prostatic hyperplasia surgery in elderly patients. Methods from January 2005 to January 2009, 60 patients with benign prostatic hyperplasia (over 80 years old) were treated in our hospital. 56 patients were treated with transurethral plasma resection of prostatic hyperplasia. 4 patients were treated with suprapubic transvesical resection. Extirpation of proliferative gland. The IPSS score, residual urine volume and maximum urinary flow (Qmax) were compared before and after operation in all patients. Results all the 60 cases were successful. The scores of IPSS, residual urine volume and maximum flow rate before operation were (20.3 鹵3.7), (85.11 鹵13.0) ml and (8.7 鹵2.1) ml/s;, respectively, without significant capsular perforation, ureteral orifice and urethral sphincter injury. The IPSS score and residual urine volume after operation were (11.5 鹵2.1), (3.7.7 鹵7.9) ml and (14.9 鹵3.2) ml/s;, respectively, and the maximum urinary flow rate (Qmax) was higher than that before operation (t = 16.02 鹵24.1412.55, P0.05). All patients were followed up for 6 ~ 12 months, no urinary incontinence, no urinary incontinence. There was no recurrence of prostatic hyperplasia. Conclusion the transurethral plasma resection of prostatic hyperplasia is safe and effective, and the recurrence rate is low in elderly patients with prostatic hyperplasia, which is worth popularizing.
【學位授予單位】：浙江大學
【學位級別】：碩士
【學位授予年份】：2014
【分類號】：R699

【參考文獻】

相關(guān)期刊論文 前1條

1 ;Efficacy and safety of combined therapy with terazosin and tolteradine for patients with lower urinary tract symptoms associated with benign prostatic hyperplasia:a prospective study[J];Chinese Medical Journal;2007年05期

，

本文編號：2230609